PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29073911-4	2017	CONCLUSIONS: We report the first case of successful replacement of treprostinil (20.1 ng/kg/min) with selexipag (1600 mug BID) as a component of triple combination therapy, which provides incentive to perform a larger, prospective exchange study.	selexipag	102-111	BH3 interacting domain death agonist	Homo sapiens	122-125